MN-25
|
- $81 - $700
- Product name: MN-25
- CAS: 501926-82-5
- MF: C26H37N3O3
- MW: 439.59
- EINECS:
- MDL Number:
- Synonyms:7-methoxy-1-(2-morpholin-4-ylethyl)-N-[(1R,3S,4S)-2,2,4-trimethyl-3-bicyclo[2.2.1]heptanyl]indole-3-carboxamide;7-methoxy-1-[2-(4-morpholinyl)ethyl]-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]hept-2-yl]-1H-indole-3-carboxamide;1H-Indole-3-carboxamide, 7-methoxy-1-[2-(4-morpholinyl)ethyl]-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]hept-2-yl]-
9 prices
Selected condition：
Brand
- aablocks
- AK Scientific
- American Custom Chemicals Corporation
- Cayman Chemical
- TRC
Package
- 1mg
- 5mg
- 10mg
- Manufactureraablocks
- Product numberAA01EP1Z
- Product description7-methoxy-1-[2-(4-morpholinyl)ethyl]-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]hept-2-yl]-1H-indole-3-carboxamide ≥95%
- Packaging1mg
- Price$132
- Updated2021-12-16
- Buy
- Manufactureraablocks
- Product numberAA01EP1Z
- Product description7-methoxy-1-[2-(4-morpholinyl)ethyl]-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]hept-2-yl]-1H-indole-3-carboxamide ≥95%
- Packaging5mg
- Price$417
- Updated2021-12-16
- Buy
- Manufactureraablocks
- Product numberAA01EP1Z
- Product description7-methoxy-1-[2-(4-morpholinyl)ethyl]-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]hept-2-yl]-1H-indole-3-carboxamide ≥95%
- Packaging10mg
- Price$700
- Updated2021-12-16
- Buy
- ManufacturerAK Scientific
- Product number6222DU
- Product descriptionUnii-8wxu5yre25
- Packaging5mg
- Price$495
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberAPI0028246
- Product descriptionMN-25 95.00%
- Packaging5MG
- Price$453.09
- Updated2021-12-16
- Buy
- ManufacturerCayman Chemical
- Product number14249
- Product descriptionMN-25 ≥95%
- Packaging1mg
- Price$81
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number14249
- Product descriptionMN-25 ≥95%
- Packaging5mg
- Price$356
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number14249
- Product descriptionMN-25 ≥95%
- Packaging10mg
- Price$632
- Updated2024-03-01
- Buy
- ManufacturerTRC
- Product numberM425515
- Product descriptionMN-25
- Packaging5mg
- Price$290
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| aablocks | AA01EP1Z | 7-methoxy-1-[2-(4-morpholinyl)ethyl]-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]hept-2-yl]-1H-indole-3-carboxamide ≥95% | 1mg | $132 | 2021-12-16 | Buy |
| aablocks | AA01EP1Z | 7-methoxy-1-[2-(4-morpholinyl)ethyl]-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]hept-2-yl]-1H-indole-3-carboxamide ≥95% | 5mg | $417 | 2021-12-16 | Buy |
| aablocks | AA01EP1Z | 7-methoxy-1-[2-(4-morpholinyl)ethyl]-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]hept-2-yl]-1H-indole-3-carboxamide ≥95% | 10mg | $700 | 2021-12-16 | Buy |
| AK Scientific | 6222DU | Unii-8wxu5yre25 | 5mg | $495 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | API0028246 | MN-25 95.00% | 5MG | $453.09 | 2021-12-16 | Buy |
| Cayman Chemical | 14249 | MN-25 ≥95% | 1mg | $81 | 2024-03-01 | Buy |
| Cayman Chemical | 14249 | MN-25 ≥95% | 5mg | $356 | 2024-03-01 | Buy |
| Cayman Chemical | 14249 | MN-25 ≥95% | 10mg | $632 | 2024-03-01 | Buy |
| TRC | M425515 | MN-25 | 5mg | $290 | 2021-12-16 | Buy |
Properties
Boiling point :631.8±55.0 °C(Predicted)
Density :1.24±0.1 g/cm3(Predicted)
solubility :DMF: 30 mg/ml; DMF:PBS (pH 7.2) (1:5): 0.16 mg/ml; DMSO: 20 mg/ml; Ethanol: 10 mg/ml
form :A crystalline solid
pka :14.37±0.60(Predicted)
InChIKey :VQGDMQICNRCQEH-UFKXBGGNSA-N
SMILES :N1(CCN2CCOCC2)C2=C(C=CC=C2OC)C(C(N[C@@H]2C(C)(C)[C@@]3([H])C[C@]2(C)CC3)=O)=C1
Density :1.24±0.1 g/cm3(Predicted)
solubility :DMF: 30 mg/ml; DMF:PBS (pH 7.2) (1:5): 0.16 mg/ml; DMSO: 20 mg/ml; Ethanol: 10 mg/ml
form :A crystalline solid
pka :14.37±0.60(Predicted)
InChIKey :VQGDMQICNRCQEH-UFKXBGGNSA-N
SMILES :N1(CCN2CCOCC2)C2=C(C=CC=C2OC)C(C(N[C@@H]2C(C)(C)[C@@]3([H])C[C@]2(C)CC3)=O)=C1
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|